BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37846541)

  • 1. The Synergistic Effect of Theranekron and Cisplatin on the Neuroblastoma (SH-SY5Y) Cell Line.
    Taspinar N
    Turk Neurosurg; 2023; 33(6):1113-1119. PubMed ID: 37846541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
    Liu HJ; Li GL; Lei PC
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y.
    Tong HX; Lu CW; Zhang JH; Ma L; Zhang JH
    Chin Med Sci J; 2007 Mar; 22(1):38-43. PubMed ID: 17441316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of MgS nanoparticles-Cisplatin-bio-conjugate on SH-SY5Y neuroblastoma cell line.
    Nalci OB; Nadaroglu H; Genc S; Hacimuftuoglu A; Alayli A
    Mol Biol Rep; 2020 Dec; 47(12):9715-9723. PubMed ID: 33191478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
    Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line.
    Liu L; Li Y; Xiong X; Qi K; Zhang C; Fang J; Guo H
    Int J Oncol; 2016 Dec; 49(6):2319-2330. PubMed ID: 27840903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of galectin-1 facilitated cisplatin sensitivity by inhibiting autophagy in neuroblastoma cells.
    Gao J; Wang W
    Chem Biol Interact; 2019 Jan; 297():50-56. PubMed ID: 30365942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer.
    Gurunathan S; Jeyaraj M; Kang MH; Kim JH
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric and Orthosteric Activators of mGluR8 Differentially Affect the Chemotherapeutic-Induced Human Neuroblastoma SH-SY5Y Cell Damage: The Impact of Cell Differentiation State.
    Jantas D; Grygier B; Zatorska J; Lasoń W
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):443-451. PubMed ID: 29753314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of survivin using YM155 induces apoptosis and chemosensitization in neuroblastomas cells.
    Liang H; Zhang L; Xu R; Ju XL
    Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2909-15. PubMed ID: 24254560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-resistant neuroblastoma cells express enhanced levels of epidermal growth factor receptor (EGFR) and are sensitive to treatment with EGFR-specific toxins.
    Michaelis M; Bliss J; Arnold SC; Hinsch N; Rothweiler F; Deubzer HE; Witt O; Langer K; Doerr HW; Wels WS; Cinatl J
    Clin Cancer Res; 2008 Oct; 14(20):6531-7. PubMed ID: 18927293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
    Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
    BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic effects of 4'-hydroxychalcone on human neuroblastoma cells (SH-SY5Y).
    de Moura Escobar SJ; Simone M; Martin N; de Oliveira Ribeiro CA; Martinez GR; Winnischofer SMB; Witting PK; Rocha MEM
    Toxicol In Vitro; 2019 Dec; 61():104640. PubMed ID: 31493544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines.
    Holzhauser S; Lukoseviciute M; Papachristofi C; Vasilopoulou C; Herold N; Wickström M; Kostopoulou ON; Dalianis T
    Int J Oncol; 2021 Feb; 58(2):211-225. PubMed ID: 33491755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
    Wang Z; Lei H; Sun Q
    Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin induces apoptosis, G0/G1 cell cycle growth arrest and mitochondrial membrane potential loss in neuroblastoma brain tumor cells.
    Wang F; Gao F; Pan S; Zhao S; Xue Y
    Drug Res (Stuttg); 2015 Feb; 65(2):91-5. PubMed ID: 24831243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GX15-070 (Obatoclax), a Bcl-2 family proteins inhibitor engenders apoptosis and pro-survival autophagy and increases Chemosensitivity in neuroblastoma.
    Cournoyer S; Addioui A; Belounis A; Beaunoyer M; Nyalendo C; Le Gall R; Teira P; Haddad E; Vassal G; Sartelet H
    BMC Cancer; 2019 Oct; 19(1):1018. PubMed ID: 31664947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells.
    Wang G; Edwards H; Caldwell JT; Buck SA; Qing WY; Taub JW; Ge Y; Wang Z
    PLoS One; 2013; 8(9):e76662. PubMed ID: 24098799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel, semi-synthetic diterpenoid 16(R and S)-phenylamino-cleroda-3,13(14), Z-dien-15,16 olide (PGEA-AN) inhibits the growth and cell survival of human neuroblastoma cell line SH-SY5Y by modulating P53 pathway.
    Hussain SS; Rafi K; Faizi S; Razzak ZA; Simjee SU
    Mol Cell Biochem; 2018 Dec; 449(1-2):105-115. PubMed ID: 29644528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells.
    Takahashi M; Ozaki T; Takahashi A; Miyauchi M; Ono S; Takada N; Koda T; Todo S; Kamijo T; Nakagawara A
    Oncogene; 2007 Aug; 26(38):5669-73. PubMed ID: 17353905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.